Effects of Oral Hypoglycemic Agents Combined With Short-term CSII on Glycemic Control in Newly-diagnosed Type 2 Diabetic Patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin; Metformin; Pioglitazone; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 09 Apr 2013 Biomarkers information updated
- 19 Nov 2011 New trial record